SCHEMBL6799195

SCHEMBL6799195

COc1ccc2c(c1)[C](O)CCO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
ALOX12 P18054 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PKM P14618 2/20 0.43
CYP19A1 P11511 1/20 0.43
PKLR P30613 1/20 0.43
LMNA P02545 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
CLK1 P49759 1/20 0.42
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10044907 0.81 RAB9A (0.43) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL12344428 0.80 ALDH1A1 (0.46) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL8221474 0.80 NPC1 (0.46) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL769313 0.80 NPC1 (0.54) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL14682173 0.80 ALDH1A1 (0.46) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL11540789 0.80 ALDH1A1 (0.46) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL11540786 0.80 ALDH1A1 (0.46) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL20205919 0.76 MAPT (0.46) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL8027812 0.76 KDM4E (0.43) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL3716710 0.75 GSK3B (0.48) MAPTRAB9ANPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6750243-B1 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis AstraZeneća AB (SE) 2004-06-15 US claimed